Physician profile
Jason C Datta
NPI 1700854296
$12,354.96
in general payments reported to CMS, 2019-2025
25 companies · $1,906 in 2025
The $1,906 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $23.27 · 2021: $3,572 · 2022: $1,256 · 2023: $345 · 2024: $4,853 · 2025: $1,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $1,710 · Travel and Lodging: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $1,710.47 |
| Travel and Lodging | $1,393.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ingeniumspine, LLC | $8,707.47 | 2021-2025 | Ingenix, Tlif Cages Cervical Cages Thoracolumbar Pedicle Screw-Rod Constructs Anterior Cervical Plates |
| Si-Bone, INC. | $1,013.78 | 2024-2025 | |
| Arthrex, INC. | $562.46 | 2025 | |
| Abbott Laboratories | $414.50 | 2019-2025 | Proclaim |
| Impactortho, INC. | $275.93 | 2025 | |
| Intrinsic Therapeutics | $222.19 | 2024-2025 | Barricaid Acd (Annular Closure Device) |
| Centinel Spine, LLC | $178.70 | 2025 | Prodisc L |
| Medtronic, INC. | $128.78 | 2022 | |
| Medtronic USA, INC. | $128.27 | 2019 | |
| Providence Medical Technology, INC. | $123.10 | 2025 | |
| Corelink, LLC | $100.00 | 2022 | |
| Globus Medical, INC. | $98.52 | 2021-2023 | Excelsiusgps Robotic Navigation System |
| Bioventus LLC | $87.65 | 2019 | |
| Saluda Medical Americas, INC. | $80.14 | 2025 | Evoke |
| Xtant Medical INC | $42.01 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $35.57 | 2019 | |
| Spinal Elements, INC. | $27.76 | 2023 | |
| Dilon Technologies, INC. | $27.56 | 2025 | Hemoblast Bellows |
| Vertex Pharmaceuticals Incorporated | $24.66 | 2025 | |
| Depuy Synthes Sales INC. | $22.12 | 2025 | Velys |
| Nevro Corp. | $21.42 | 2022 | |
| Ethicon US, LLC | $18.45 | 2024 | Minivac |
| Boston Scientific Corporation | $13.92 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,200,038.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Datta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.